MXPA03002986A - Derivados de 7-carboxiflavona, procedimiento de preparacion y aplicacion terapeutica. - Google Patents

Derivados de 7-carboxiflavona, procedimiento de preparacion y aplicacion terapeutica.

Info

Publication number
MXPA03002986A
MXPA03002986A MXPA03002986A MXPA03002986A MXPA03002986A MX PA03002986 A MXPA03002986 A MX PA03002986A MX PA03002986 A MXPA03002986 A MX PA03002986A MX PA03002986 A MXPA03002986 A MX PA03002986A MX PA03002986 A MXPA03002986 A MX PA03002986A
Authority
MX
Mexico
Prior art keywords
group
carboxy
preparation
therapeutic use
alkaline
Prior art date
Application number
MXPA03002986A
Other languages
English (en)
Inventor
Suzy Charbit
Original Assignee
Negma Lerads
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Negma Lerads filed Critical Negma Lerads
Publication of MXPA03002986A publication Critical patent/MXPA03002986A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invencion se refiere a nuevos derivados de flavona e isoflavona de la formula (Ia) y (Ib), en donde X representa un grupo de la formula -COOR, o -PO(OR)2; R representa un atomo de hidrogeno o un metal alcalino o alcalino-terreo, o un grupo alquilo inferior; R1 representa un grupo hidroxi, un grupo alcoxi inferior o un grupo aciloxi; R2 y R3, identicos o diferentes representan un atomo de hidrogeno o de halogeno, o un grupo trifluorometil, un grupo triclorometil, un grupo hidroxi, un grupo alcoxi o un grupo aciloxi; el grupo comprende de 1 a 5 atomos de carbono, o R2 y R3 se pueden combinar para formar un grupo dioxi-alquileno. El invento es util para el tratamiento de males reumaticos.
MXPA03002986A 2000-10-06 2001-10-05 Derivados de 7-carboxiflavona, procedimiento de preparacion y aplicacion terapeutica. MXPA03002986A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0012846A FR2815033B1 (fr) 2000-10-06 2000-10-06 Derives de 7-carboxy-flavones, porcede pour leur preparation et leur application en therapeutique
PCT/FR2001/003075 WO2002028851A1 (fr) 2000-10-06 2001-10-05 Dérivés de 7-carboxy-flavones, procédé de préparation et application en thérapeutique

Publications (1)

Publication Number Publication Date
MXPA03002986A true MXPA03002986A (es) 2004-05-24

Family

ID=8855113

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03002986A MXPA03002986A (es) 2000-10-06 2001-10-05 Derivados de 7-carboxiflavona, procedimiento de preparacion y aplicacion terapeutica.

Country Status (15)

Country Link
US (1) US6965039B2 (es)
EP (1) EP1212313B1 (es)
JP (1) JP2004510770A (es)
CN (1) CN1301987C (es)
AT (1) ATE241609T1 (es)
AU (1) AU2001293956A1 (es)
BR (1) BR0114457A (es)
CA (1) CA2424993A1 (es)
DE (1) DE60100314T2 (es)
DK (1) DK1212313T3 (es)
ES (1) ES2199213T3 (es)
FR (1) FR2815033B1 (es)
MX (1) MXPA03002986A (es)
PT (1) PT1212313E (es)
WO (1) WO2002028851A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100841901B1 (ko) * 2002-03-18 2008-06-27 동화약품공업주식회사 플라보노이드 계열 화합물 또는 이를 포함하는 강진향추출물을 함유한 매트릭스 메탈로프로테이나제 활성저해제 및 기능성 식품
GB0412768D0 (en) * 2004-06-08 2004-07-07 Novartis Ag Organic compounds
GB0412769D0 (en) 2004-06-08 2004-07-07 Novartis Ag Organic compounds
EP2182801A4 (en) * 2007-07-31 2011-04-13 Limerick Biopharma Inc COMPOSITIONS OF PYRONE ANALOGS AND METHODS
WO2009018338A2 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Phosphorylated pyrone analogs and methods
US20100297020A1 (en) * 2008-10-10 2010-11-25 Limerick Biopharma, Inc. Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
JP2012525331A (ja) * 2009-04-27 2012-10-22 リメリック バイオファーマ, インコーポレイテッド 治療的処置のためのリン酸化ピロン類似体
CN108329287B (zh) * 2018-02-24 2020-06-16 海南师范大学 大果榕中带有环氧基的化合物及其制备方法和应用
CN111388464A (zh) * 2020-04-28 2020-07-10 滨州医学院 芒柄花素磺酸钠在制备治疗类风湿性关节炎药物中的应用
CN111875571A (zh) * 2020-07-23 2020-11-03 长沙理工大学 一种从酱油渣中提取大豆异黄酮的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4157334A (en) 1974-12-26 1979-06-05 Carlo Erba S. P. A. 6-Carboxy-flavone derivatives and process for their preparation
FR2543140B1 (fr) 1983-03-24 1985-06-21 Cortial Nouveaux acides flavone-carboxyliques-4', leur methode de preparation et leur application en therapeutique
JPS62215581A (ja) 1986-03-18 1987-09-22 Koichi Shiyudo フラボンカルボン酸誘導体
DE3715779A1 (de) 1987-05-12 1988-11-24 Kali Chemie Pharma Gmbh Flavon-3-carbonsaeure-verbindungen sowie verfahren, zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2689127B1 (fr) 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5399584A (en) 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP3957795B2 (ja) * 1996-10-04 2007-08-15 興和株式会社 フラボン誘導体及びこれを含有する医薬

Also Published As

Publication number Publication date
WO2002028851A1 (fr) 2002-04-11
ES2199213T3 (es) 2004-02-16
PT1212313E (pt) 2003-10-31
DE60100314D1 (de) 2003-07-03
AU2001293956A1 (en) 2002-04-15
ATE241609T1 (de) 2003-06-15
US6965039B2 (en) 2005-11-15
BR0114457A (pt) 2003-10-21
DK1212313T3 (da) 2003-09-22
US20040059136A1 (en) 2004-03-25
EP1212313A1 (fr) 2002-06-12
FR2815033A1 (fr) 2002-04-12
JP2004510770A (ja) 2004-04-08
CN1301987C (zh) 2007-02-28
CN1468228A (zh) 2004-01-14
DE60100314T2 (de) 2004-04-01
FR2815033B1 (fr) 2003-09-05
CA2424993A1 (fr) 2002-04-11
EP1212313B1 (fr) 2003-05-28

Similar Documents

Publication Publication Date Title
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
NZ513561A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
NZ307509A (en) Use of 1L agonists in the treatment of incontinence
NZ333706A (en) Benzenesulfone derivatives and medicaments
MXPA03002986A (es) Derivados de 7-carboxiflavona, procedimiento de preparacion y aplicacion terapeutica.
TNSN03144A1 (en) Pyrrolopyrimidines as protein kinase inhibitors
GB0005251D0 (en) Therapeutic compounds
DE60112974D1 (en) Carbolinderivate
NZ334976A (en) Benzonaphthyridine derivatives and their use for treating airway disorders and dermatoses
NZ522368A (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
SG50663A1 (en) 1,2,4-Oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
AU2002213421A1 (en) Condensed pyridoindole derivatives
ES2187261A1 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
MXPA02012076A (es) Compuestos quimicos.
DK2308496T3 (da) Formulering indeholdende fosfatderivater af elektrontransfermidler
MXPA02012659A (es) Derivados de pirazindiona condensados.
PL352638A1 (en) Novel derivatives and analogues of galanthamin
DE60112960D1 (de) Kondensierte pyridoindolderivate
WO2002012188A3 (en) Indole compounds useful for the treatment of cancer
ATE296827T1 (de) Heteropolycyclische inhibitoren
EP1353669A4 (en) METHOD FOR TREATING GLAUCOMA
WO2002038563A3 (en) Condensed pyrazindione derivatives as pde inhibitors
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
EP0994113A3 (en) 7-Aminopyrido(2,3-d)-pyrimidine derivatives for treatment of bronchial asthma
NZ332348A (en) use of triphenylethylene derivatives as antioxidant agents

Legal Events

Date Code Title Description
FG Grant or registration